Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C36H42O17 |
| Molecular Weight | 746.7085 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 16 / 16 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@]6(O[C@]3([H])O[C@H](COC(=O)C4=CC=CC=C4)[C@@H](O[C@]5([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]3O)[C@]1(COC(=O)C7=CC=CC=C7)[C@@]8([H])O[C@]2(O)C[C@]6(C)O8
InChI
InChIKey=QREQQDSOBGSTFM-XXBRTPTLSA-N
InChI=1S/C36H42O17/c1-33-15-35(45)21-12-36(33,34(21,32(52-33)53-35)16-47-29(44)18-10-6-3-7-11-18)51-31-26(42)24(40)27(50-30-25(41)23(39)22(38)19(13-37)48-30)20(49-31)14-46-28(43)17-8-4-2-5-9-17/h2-11,19-27,30-32,37-42,45H,12-16H2,1H3/t19-,20-,21-,22-,23+,24-,25-,26-,27-,30+,31+,32-,33+,34+,35-,36+/m1/s1
| Molecular Formula | C36H42O17 |
| Molecular Weight | 746.7085 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 16 / 16 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:13:23 UTC 2023
by
admin
on
Sat Dec 16 09:13:23 UTC 2023
|
| Record UNII |
0WR0ZSG99C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0WR0ZSG99C
Created by
admin on Sat Dec 16 09:13:23 UTC 2023 , Edited by admin on Sat Dec 16 09:13:23 UTC 2023
|
PRIMARY | |||
|
71452334
Created by
admin on Sat Dec 16 09:13:23 UTC 2023 , Edited by admin on Sat Dec 16 09:13:23 UTC 2023
|
PRIMARY | |||
|
1415091-25-6
Created by
admin on Sat Dec 16 09:13:23 UTC 2023 , Edited by admin on Sat Dec 16 09:13:23 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Anticomplement Activity (50% hemolytic inhibition) through the Classical Pathway (CP) and Alternative Pathway (AP) for compound tested was found to be CH50 2.29 ? 0.12 (mM) and for AP50, to produce no inhibitory effect respectively.
|
